Key result
Atrial fibrillation linked to ~32.8-fold higher odds of LVEF decline to <50% on mavacamten.
Why the study?
Mavacamten inhibits cardiac contractility in obstructive hypertrophic cardiomyopathy, making reduced LVEF its main adverse effect, and predictors of this systolic dysfunction needed evaluation.
What baseline clinical and imaging characteristics predict left ventricular systolic dysfunction (LVEF <50%) in symptomatic obstructive hypertrophic cardiomyopathy patients treated with mavacamten?
Cohort (n=73)
Yes
What baseline clinical and imaging characteristics predict left ventricular systolic dysfunction (LVEF <50%) in symptomatic obstructive hypertrophic cardiomyopathy patients treated with mavacamten?
Identifies atrial fibrillation as a strong independent predictor of LVEF decline (<50%) during mavacamten therapy in obstructive HCM, with borderline associations for pacemaker rhythm, lower baseline CMR LVEF, and higher LGE burden.
Answers are grounded in this paper and cite their sources.
AF may warrant closer LVEF monitoring during mavacamten in oHCM; leaves open whether it modifies treatment selection or requires prospective validation.
Introduction Mavacamten, currently approved to treat patients with obstructive hypertrophic cardiomyopathy (oHCM), reduces left ventricular outflow tract (LVOT) gradient through inhibition of cardiac contractility. Owing to its mechanism of action, its main adverse effect is reduced left ventricular ejection fraction (LVEF), often requiring temporary treatment suspension. Aim To evaluate predictors of reduced LVEF in a cohort of patients treated with mavacamten. Methods We conducted a prospective, observational, multicenter study of symptomatic oHCM patients enrolled in an Early Access Program for mavacamten at three centers. Baseline demographic, clinical, echocardiographic, cardiac magnetic resonance (CMR), cardiopulmonary exercise testing, and electrocardiographic data were collected and analyzed as potential predictors of "systolic dysfunction" during treatment, defined as an LVEF decline to <50%, using a logistic regression model. Given the anticipated low number of events, variables with a p-value <0.100 were considered for inclusion in the multivariable analysis to assess their strength as independent predictors. Results 73 patients were included (median age 67 years [IQR 59–72], 32.9% male). The mean resting LVOT gradient at baseline was 62 ± 37 mmHg, and 102 ± 43 mmHg with Valsalva. All patients had been receiving mavacamten for at least one month. Nine patients (10.8%) required treatment suspension due to reduced LVEF, of whom two discontinued therapy permanently. In univariate analysis, variables associated with the outcome included atrial fibrillation (p=0.054) or pacemaker rhythm (p=0.019), age (p=0.094), LVEF on baseline CMR (p=0.048), and percentage of late gadolinium enhancement (p=0.065). Mavacamten dosage was not associated with the outcome (p=0.805). In multivariable analysis, atrial fibrillation was the strongest independent predictor (p=0.020; OR 32.8). Pacemaker rhythm (p=0.066), baseline LVEF (p=0.073), and percentage of late gadolinium enhancement (LGE) (p=0.084) were borderline predictors, whereas age was not independently associated with the outcome (p=0.120). Conclusion In our cohort, atrial fibrillation independently predicted LVEF dysfunction during mavacamten therapy, while lower baseline LVEF, greater LGE burden on CMR, and pacemaker rhythm demonstrating borderline associations with the primary outcome.
No takes yet. Share an insight, caveat, or question.
Lopes et al. (2026) conducted a cohort in Obstructive hypertrophic cardiomyopathy (oHCM) (n=73). Atrial fibrillation (among oHCM patients treated with mavacamten) vs. Absence of atrial fibrillation was evaluated on Systolic dysfunction during mavacamten treatment, defined as an LVEF decline to <50% requiring treatment suspension (OR 32.8, p=0.020). Atrial fibrillation independently predicted LVEF decline to <50% during mavacamten therapy in oHCM patients, occurring overall in 10.8% of the cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: